首页> 美国卫生研究院文献>Journal of the National Medical Association >Antimicrobial susceptibility survey of Pseudomonas aeruginosa strains isolated from clinical sources.
【2h】

Antimicrobial susceptibility survey of Pseudomonas aeruginosa strains isolated from clinical sources.

机译:从临床来源分离出的铜绿假单胞菌菌株的药敏试验。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A two-year prospective study of 554 Pseudomonas aeruginosa isolates was recovered from various clinical sources throughout Trinidad, and their resistance patterns to antipseudomonal antimicrobial agents were determined. Of the 554 P. aeruginosa isolates, 20.6% (114/554) were community isolates, 17.3% (96/554) from the intensive care unit (ICU), 10.1% (56/554) from the nursery, and the remaining 52% (288/554) were from other hospital inpatient services. Respiratory tract infections were the predominant source of P. aeruginosa isolates from the ICU--46.9% (45/96)--and nursery--21.4% (12/56), whereas wounds were the principal source of P. aeruginosa from the surgical services--77.0% (141/183). Community isolates of P. aeruginosa were predominantly from ear--100% (51/51)--and urinary tract infections--35.5%, (33/93). The overall prevalence of resistance was low for both hospital isolates (13.9%) and community isolates (3.8%). All community isolates were fully sensitive to four of the nine antimicrobials tested. Resistance rates among community strains ranged from 2.6% (ciprofloxacin and ceftazidime) to 12.3% for piperacillin. All isolates from hospital were fully sensitive to imipenem, but resistance rates for the other drugs ranged between 2.5% and 27.3%. The study showed that the overall resistance pattern of P. aeruginosa was relatively low. This is an encouraging observation but invites caution since resistance to the newly introduced drug, cefepime, has now emerged within the hospital environment and may present serious therapeutic problems within the near future. Policies governing the use of antimicrobials in many institutions are lacking. Such policies must be instituted in order to limit the spread of resistance and also to reduce the emergence of resistance to newly commissioned drugs within the country.
机译:从特立尼达的各种临床来源中回收了554种铜绿假单胞菌分离株,进行了为期两年的前瞻性研究,并确定了它们对抗假单胞菌抗菌剂的耐药模式。在554株铜绿假单胞菌分离株中,有20.6%(114/554)是社区分离株,来自重症监护病房(ICU)的占17.3%(96/554),来自苗圃的10.1%(56/554)。 %(288/554)来自其他医院的住院服务。呼吸道感染是来自ICU--46.9%(45/96)和苗圃--21.4%(12/56)的铜绿假单胞菌分离株的主要来源,而伤口是来自ICU的铜绿假单胞菌的主要来源。外科服务--77.0%(141/183)。铜绿假单胞菌的社区分离株主要来自耳-100%(51/51)和尿路感染-35.5%(33/93)。医院分离株(13.9%)和社区分离株(3.8%)的总体耐药率均较低。所有社区分离株均对所测试的九种抗菌药物中的四种完全敏感。社区菌株的耐药率范围从2.6%(环丙沙星和头孢他啶)到哌拉西林的12.3%。医院的所有分离株对亚胺培南完全敏感,但其他药物的耐药率介于2.5%和27.3%之间。研究表明,铜绿假单胞菌的总体抗性模式较低。这是令人鼓舞的观察,但请谨慎,因为对新引入的药物头孢吡肟的耐药性现已在医院环境中出现,并可能在不久的将来带来严重的治疗问题。在许多机构中缺乏管理抗菌药物使用的政策。必须制定此类政策,以限制耐药性的蔓延并减少对该国新委托药物的耐药性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号